Lessee, Operating Lease, Liability, to be Paid, Year Two of Sonnet BioTherapeutics Holdings, Inc. from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2024 was $48,216, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $48,216 -$47,271 -50% 30 Sep 2024 10-K 17 Dec 2024 2024 FY
Q3 2023 $95,487 +$1,873 +2% 30 Sep 2023 10-K 14 Dec 2023 2023 FY
Q3 2022 $93,614 +$58,919 +170% 30 Sep 2022 10-K 15 Dec 2022 2022 FY
Q2 2022 $93,614 -$9,826 -9.5% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q3 2021 $34,695 -$68,745 -66% 30 Sep 2021 10-K 17 Dec 2021 2021 FY
Q2 2021 $103,440 $0 0% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 $103,440 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 $103,440 -$3,128,097 -97% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $103,440 30 Sep 2020 10-K 17 Dec 2020 2020 FY
Q2 2020 $103,440 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q4 2019 $3,231,537 31 Dec 2019 10-K 19 Mar 2020 2019 FY
Q1 2019 $3,741,405 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.